Whole Body Health Sale

Life Extension Magazine





May 9, 2000

 

National Academy of Sciences References


 

136. Shah GM, et al. Effects of Ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients. Am J Kidney Dis 1992 Jul;20(1):42-9.

137. Niki E. Interaction of ascorbate and alpha-tocopherol. Ann N Y Acad Sci 1987;498:186-99.

138. Chan AC, et al. Partners in defense, vitamin E and vitamin C. Can J Physiol Pharmacol 1993 Sep;71(9):725-31.

139. Bielory L, et al. Asthma and vitamin C. Ann Allergy 1994 Aug;73(2):89-96; quiz 96-100.

140. Hunt C, et al. The clinical effects of vitamin C supplementation in elderly hospitalized patients with acute respiratory infections. Int J Vitam Nutr Res 1994;64(3):212-9.

141.Nowak D, et al. Effect of ascorbic acid on hydroxyl radical generation by chemical, enzymatic and cellular systems. Importance for antioxidant prevention of pulmonary emphysema. Biomed Biochim Acta 1991;50(3):265-72.

142.Yu AB, et al.Oxidation kinetics of an antiasthmatic, 2-[(4-hydroxyphenyl)amino]-5-methoxybenzenemethanol, and stabilization with ascorbic acid.
J Pharm Sci 1990 Oct;79(10):913-5.

143. Anderson R, et al. Ascorbic acid in bronchial asthma. S Afr Med J 1983 Apr 23;63(17):649-52.

144. Mohsenin V, et al. Effect of ascorbic acid on response to methacholine challenge in asthmatic subjects. Am Rev Respir Dis 1983 Feb;127(2):143-7.

145. Miric M, et al. [Effect of vitamin C on exercise-induced bronchoconstriction]. [Article in Serbo-Croatian (Roman)] Plucne Bolesti 1991 Jan-Jun;43(1-2):94-7.

146. Anderson R, et al. The effect of ascorbate on cellular humoral immunity in asthmatic children. S Afr Med J 1980 Dec 13;58(24):974-7.

147. Anah CO, et al. High dose ascorbic acid in Nigerian asthmatics. Trop Geogr Med 1980 Jun;32(2):132-7.

148. Paleologos M, et al. Cohort study of vitamin C intake and cognitive impairment. Am J Epidemiol 1998 Jul 1;148(1):45-50.

149. Lenton KJ, et al. Direct correlation of glutathione and ascorbate and their dependence on age and season in human
lymphocytes. Am J Clin Nutr 2000 May;71(5):1194-200.

150. Jain A, et al. Effect of ascorbate or N-acetylcysteine treatment in a patient with hereditary glutathione synthetase deficiency. J Pediatr 1994 Feb;124(2):229-33.

151.Dubey SS, et al. Ascorbic acid, dehydroascorbic acid and glutathione in liver disease. Indian J Physiol Pharmacol 1987 Oct-Dec;31(4):279-83.

152. Gorton HC, et al. The effectiveness of vitamin C in preventing and relieving the symptoms of virus-induced respiratory infections. J Manipulative Physiol Ther 1999 Oct;22(8):530-3.

153. Hemila H, et al. Vitamin C and acute respiratory infections. Int J Tuberc Lung Dis 1999 Sep;3(9):756-61 Int J Tuberc Lung Dis 1999 Sep;3(9):756-61.

154.Gonul B, et al. Effects of vitamin C supplementation on plasma antioxidant status in unfed periods. Gen Pharmacol 1999 Feb;32(2):195-9.

155. Negre-Salvayre A, et al. alpha-Tocopherol, ascorbic acid, and rutin inhibit synergistically the copper-promoted LDL oxidation and the cytotoxicity of oxidized LDL to cultured endothelial cells. Biol Trace Elem Res 1995 Jan-Mar;47(1-3):81-91.

156. Harwood HJ Jr, et al. Inhibition of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by ascorbic acid. An effect mediated by the free radical monodehydroascorbate. J Biol Chem 1986 Jun 5;261(16):7127-35.

157. Panda K, et al. Vitamin C prevents cigarette smoke induced oxidative damage of proteins and increased proteolysis. Free Radic Biol Med 1999 Nov;27(9-10):1064-79.

158. Lee BM, et al. Inhibition of oxidative DNA damage, 8-OHdG, and carbonyl contents in smokers treated with antioxidants (vitamin E, vitamin C, beta-carotene and red ginseng). Cancer Lett 1998 Oct 23;132(1-2):219-27.

159. Helen A, et al. Vitamin C supplementation on hepatic oxidative stress induced by cigarette smoke. J Appl Toxicol 1997 Sep-Oct;17(5):289-95.

160. Menzel DB Antioxidant vitamins and prevention of lung disease. Ann N Y Acad Sci 1992 Sep 30;669:141-55.

161. Banic S. Immunostimulation by vitamin C. Int J Vitam Nutr Res Suppl 1982;23:49-52.

162. Beyer RE The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q. J Bioenerg Biomembr 1994 Aug;26(4):349-58.

163. Kromhout D, et al.Saturated fat, vitamin C and smoking predict long-term population all-cause mortality rates in the Seven Countries Study. Int J Epidemiol 2000 Apr;29(2):260-5.

164. Houston DK, et al. Does vitamin C intake protect against lead toxicity? Nutr Rev 2000 Mar;58(3 Pt 1):73-5.

165. Douglas RM, et al. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2000;2:CD000980.

166. Young VR. Evidence for a recommended dietary allowance for vitamin C from pharmacokinetics: a comment and analysis. Proc Natl Acad Sci U S A 1996 Dec 10;93(25):14344-.

167. Salonen JT. Selenium in ischaemic heart disease. Int J Epidemiol, 1987 Jun, 16:2, 323-8.

168. Paolisso G, et al. Primary and secondary prevention of atherosclerosis: is there a role for antioxidants? Diabetes Metab, 1999 Sep, 25:4, 298-306.

169. Hercberg S, et al. "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants. Food Chem Toxicol, 1999 Sep, 37:9-10, 925-30.

170. Paolisso G, et al. Primary and secondary prevention of atherosclerosis: is there a role for antioxidants? Diabetes Metab 1999 Sep;25(4):298-306.

171. Neve J. Selenium and cardiovascular pathology. Source Pathol Biol (Paris), 1989 Dec, 37:10, 1102-6.

172. Dubois F, et al. [Selenium: physiologic role and value in human pathology]Pathol Biol (Paris), 1988 Oct, 36:8, 1017-25.

173. Virtamo J, et al. Serum selenium and the risk of coronary heart disease and stroke. Source Am J Epidemiol, 1985 Aug, 122:2, 276-82.

174. Kok FJ, et al. Selenium status and chronic disease mortality: Dutch epidemiological findings. Int J Epidemiol, 1987 Jun, 16:2, 329-32.

175. Ringstad J, et al. The TromsI Heart Study: serum selenium in a low-risk population for cardiovascular disease and cancer and matched controls. Ann Clin Res, 1987, 19:5, 351-4.

176. Berr C, et al. Demographic and cardiovascular risk factors in relation to antioxidant status: the EVA Study. Int J Vitam Nutr Res, 1998, 68:1, 26-35.

177. Jackson ML. Selenium: geochemical distribution and associations with human heart and cancer death rates and longevity in China and the United States. Biol Trace Elem Res, 1988 Jan, 15:, 13-21.

178. van de Vijver LP, et al. Lipoprotein oxidation, antioxidants and cardiovascular risk: epidemiologic evidence. Prostaglandins Leukot Essent Fatty Acids, 1997 Oct, 57:4-5, 479-87.

179. Crary EJ, et al. Potential clinical applications for high-dose nutritional antioxidants. Med Hypotheses, 1984 Jan, 13:1, 77-98.

180. Suadicani P, et al. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis, 1992 Sep, 96:1, 33-42.

181. Barceloux DG. Selenium. J Toxicol Clin Toxicol, 1999, 37:2, 145-72.

182. Huttunen JK. Selenium and cardiovascular diseases--an update. Biomed Environ Sci, 1997 Sep, 10:2-3, 220-6.

183. Neve J. Selenium and cardiovascular pathology. Pathol Biol (Paris), 1989 Dec, 37:10, 1102-6.

184. Kardinaal AF, et al. Association between beta-carotene and acute myocardial infarction depends on polyunsaturated fatty acid status. The EURAMIC Study. European Study on Antioxidants, Myocardial Infarction, and Cancer of the Breast. Arterioscler Thromb Vasc Biol, 1995 Jun, 15:6, 726-32.

185. van Poppel G, et al. Antioxidants and coronary heart disease. Ann Med, 1994 Dec, 26:6, 429-34.

186. Vitoux D, et al. Selenium, glutathione peroxidase, peroxides and platelet functions. Ann Biol Clin (Paris), 1996, 54:5, 181-7.

187. Nève J . Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk, 1996 Feb, 3:1, 42-7.

188. Odeh RM, et al. Natural antioxidants for the prevention of atherosclerosis. Pharmacotherapy, 1995 Sep, 15:5, 648-59.

189. Ginter E. Nutrition in the prevention of ischemic heart disease Bratisl Lek Listy, 1989 Mar, 90:3, 203-21.

190. Kendler BS. Recent nutritional approaches to the prevention and therapy of cardiovascular disease. Prog Cardiovasc Nurs, 1997 Sum, 12:3, 3-23.

191. Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Interact, 1994 Jun, 91:2-3, 181-6.

192. Virtamo J. Serum selenium and the risk of coronary heart disease and stroke. Am J Epidemiol, 1985 Aug, 122:2, 276-82.

193. Kok FJ, et al. Selenium status and chronic disease mortality: Dutch epidemiological findings. Int J Epidemiol, 1987 Jun, 16:2, 329-32.

194. Ellis NI, et al. Selenium and vitamin E in relation to risk factors for coronary heart disease. J Clin Pathol, 1984 Feb, 37:2, 200-6.

195. Huttunen JK . Selenium and cardiovascular diseases--an update. Biomed Environ Sci, 1997 Sep, 10:2-3, 220-6.

196. Coudray C, et al. Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France). J Am Coll Nutr, 1997 Dec, 16:6, 584-91.

197. Lush DT. Preventing heart disease and cancer. What randomized, primary-prevention studies show. Postgrad Med 1999 Oct 15;106(5):143-8.

198. Yu SY, et al. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res 1997 Jan;56(1):117-24.

199. Taylor EW, et al. Genomic structures of viral agents in relation to the biosynthesis of selenoproteins. Biol Trace Elem Res, 1997 Jan, 56:1, 63-91.

200. Zhang W, et al. Hepatitis C virus encodes a selenium-dependent glutathione peroxidase gene. Implications for oxidative stress as a risk factor in progression to hepatocellular carcinoma. Source Med Klin, 1999 Oct, 94 Suppl 3:, 2-6.

201. Peterhans E. Reactive oxygen species and nitric oxide in viral diseases. Biol Trace Elem Res, 1997 Jan, 56:1, 107-16.

202. Beck MA, et al. Dietary oxidative stress and the potentiation of viral infection. Annu Rev Nutr, 1998, 18:, 93-116.

203. Look MP, et al. Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial. Antiviral Res, 1999 Sep, 43:2, 113-22.

204. Seitz HK, et al. Alcohol and cancer. Recent Dev Alcohol, 1998, 14:, 67-95.

205. Zhang W, et al. Selenium-dependent glutathione peroxidase modules encoded by RNA viruses. Biol Trace Elem Res 1999 Nov;70(2):97-116.

206. Chemoprevention trial of human hepatitis with selenium supplementation in China. Biol Trace Elem Res 1989 Apr-May;20(1-2):15-22.

207. Campa A, et al. Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol, 1999 Apr, 20:5, 508-13.

208. Campa A, et al. Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol 1999 Apr 15;20(5):508-13.

209. Baum MK, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997 Aug.

210. Baum MK, et al. Micronutrient status in relationship to mortality in HIV-1 disease. Nutr Rev 1998 Jan;56(1 Pt 2):S135-9.

211. Look MP, et al. Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection. Eur J Clin Nutr. 1997 Apr;51(4):266-72.

212. Periquet BA, et al. Micronutrient levels in HIV-1-infected children. AIDS, 1995 Aug, 9:8, 887-93.

213. Hori K, et al. Selenium supplementation suppresses tumor necrosis factor alpha-induced human immunodeficiency virus type 1 replication in vitro. AIDS Res Hum Retroviruses, 1997 Oct, 13:15, 1325-32.

214. McCarty MF. natural antimutagenic agents may prolong efficacy of human immunodeficiency virus drug therapy. Med Hypotheses, 1997 Mar, 48:3, 215-20.

215. Cirelli A, et al. Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem, 1991 Apr, 24:2, 211-4.
Look MP, et al. Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection. Eur J Clin Nutr, 1997 Apr, 51:4, 266-72.

217. Constans J, et al. Selenium and HIV infection [editorial] Nutrition, 1999 Sep, 15:9, 719-20.

218. Olmsted L, et al. Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol Trace Elem Res, 1989 Apr, 20:1-2, 59-65.

219. Taylor EW, et al. Genomic structures of viral agents in relation to the biosynthesis of selenoproteins. Biol Trace Elem Res, 1997 Jan, 56:1, 63-91.

220. Sappey C, et al. Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency. Clin Chim Acta 1994 Oct 14;230(1):35-42.

221. Patrick L. Nutrients and HIV: part two--vitamins A and E, zinc, B-vitamins, and magnesium. Altern Med Rev 2000 Feb;5(1):39-51.

222. Constans J, et al. Selenium and HIV infection. Nutrition 1999 Sep;15(9):719-20.

223. May SW, et al. Selenium-based antihypertensives. Rationale and potential. Drugs 1998 Dec;56(6):959-64.

224. Rabaud C, et al. [Free radicals and HIV infection]. Ann Biol Clin (Paris) 1997 Nov-Dec;55(6):565-71.

225. Brown NA, et al. Nutrition supplements and the eye. Eye 1998;12 ( Pt 1):127-33.

226. Sperduto RD, et al. The Linxian cataract studies. Two nutrition intervention trials. Arch Ophthalmol 1993 Sep;111(9):1246-53.

227. Knekt P, et al. Serum antioxidant vitamins and risk of cataract. BMJ 1992 Dec 5;305(6866):1392-4.

228. Remarkable success of antioxidant treatment (selenomethionine and vitamin E) to a 34-year old patient with posterior subcapsular cataract, keratoconus, severe atopic eczema and asthma. Acta Ophthalmol (Copenh), 1988 Apr, 66:2, 237-8.

229. Karaküçük S, et al. Selenium concentrations in serum, lens and aqueous humour of patients with senile cataract. Acta Ophthalmol Scand, 1995 Aug, 73:4, 329-32.

230. Taylor A. Associations between nutrition and cataract. Nutr Rev, 1989 Aug, 47:8, 225-34.

231. Sperduto RD, et al. The Linxian cataract studies. Two nutrition intervention trials. Arch Ophthalmol, 1993 Sep, 111:9, 1246-53.

232. Christen WG, et al. Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol 2000 Feb;10(2):125-3.

233. Orhan H, et al. Effects of some probable antioxidants on selenite-induced cataract formation and oxidative stress-related parameters in rats. Toxicology 1999 Dec 6;139(3):219-32.

234. Sperduto RD, et al. The Linxian cataract studies. Two nutrition intervention trials. Arch Ophthalmol 1993 Sep;111(9):1246-53.

235. Helmy M.H, et al. Effect of selenium supplementation on the activities of glutathione metabolizing enzymes in human hepatoma Hep G2 cell line. Toxicology (Ireland) 03 APR 2000, 144/1-3 (57-61).

236. Zimmermann M.B, et al. Effect of oral iodized oil on thyroid size and thyroid hormone metabolism in children with concurrent selenium and iodine deficiency European Journal of Clinical Nutrition (United Kingdom) 2000, 54/3 (209-213).

237. Reimund J.-M., Antioxidant and immune status in active Crohn's disease. A possible relationship. Clinical Nutrition (UK) 2000, 19/1 (43-48).

238. Alfthan G, et al. Selenium supplementation of children in a selenium-deficient area in China: Blood selenium levels and glutathione peroxidase activities. Biological Trace Element Research 2000, 73/2 (113-125).

239. Kiremidjian-Schumacher L, et al. Selenium and immunocompetence in patients with head and neck cancer. Biological Trace Element Research 2000, 73/2 (97-111).

240. Hatanaka N, et al. Selenium kinetics and changes in glutathione peroxidase activities in patients receiving long-term parenteral nutrition and effects of supplementation with selenite Nutrition 2000, 16/1 (22-26).

241. Byers T. What can randomized controlled trial tell us about nutrition and cancer prevention? Cancer Journal for Clinicians 1999, 49/6 (353-361).

242. Reimund J.-M, et al. Chronic radiation enteritis: The importance of selenium monitoring Nutrition Clinique et Metabolisme ( NUTR. CLIN. METAB.) (France) 1999, 13/2 (99-104).

243. Chandra R.K. Symposium on 'nutrition, infection and immunity' - Nutrition and immunology: From the clinic to cellular biology and back again. Proceedings of the Nutrition Society 1999, 58/3 (681-683).

244. Richard M.-J, et al. Micronutrients and ageing: Intakes and requirements Proceedings of the Nutrition Society (United Kingdom ) 1999, 58/3 (573-578).

245. Forceville X, et al. Selenium and sepsis. Nutrition Clinique et Metabolisme (France) 1999, 13/3 (177-186).

246. Kuroki F, et al. Selenium deficiency in Crohn's disease on long-term enteral nutrition: Report of a case. Kawasaki Medical Journal (Japan) 1999, 25/1 (23-27).

247. Racek J, et al. The influence of supplementation with vitamins and trace elements on markers of antioxidative defence in patients with rheumatic diseases. Klinicka Biochemie a Metabolismus (CzechRepublic) 1999, 7/4 (239-242).

248. Lasch K, et al. Selenium in therapy of colorectal cancer? Medizinische Klinik (Germany) 15 OCT 1999, 94/SUPPL. 3 (97-100).

249. Head K.A. Natural therapies for ocular disorders, Part one: Diseases of the retina Alternative Medicine Review 1999, 4/5 (342-359).

250. Geelhoed G.W. Metabolic maladaptation: Individual and social consequences of medical intervention in correcting endemic hypothyroidism. Nutrition 1999, 15/11-12 (908-932).

251. Duffield A.J., et al. An estimation of selenium requirements for New Zealanders American Journal of Clinical Nutrition 1999, 70/5 (896-903).

252. Prasad K.N, et al. Multiple antioxidants in the prevention and treatment of Parkinson's disease. Journal of the American College of Nutrition 1999, 18/5 (413-423).

253. Angstwurm M.W.A, et al. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Critical Care Medicine 1999, 27/9(1807-1813).

254. Caspi O, et al. Parkinson's disease: "Don't become your disease!" Integrative Medicine 1999, 2/1 (37-42).

255. Geerling B.J., et al. Nutrition and inflammatory bowel disease: An update Scandinavian Journal of Gastroenterology, Norway) 1999, 33/230 (95-105).

256. Metnitz P.G.H., et al. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Medicine (Germany) 1999, 25/2 (180-185).

257. Zima T, et al. Trace elements in end-stage
renal disease. Blood Purification (Switzerland) 1999, 17/4 (187-198).

258. Bowrey D.J., et al. Selenium deficiency and chronic pancreatitis: Disease mechanism and potential for therapy HPB Surgery (United Kingdom) 1999, 11/4 (207-216).

259. De Munck-Khoe L.K., et al.Micronutrients are synergists, not solo performers. Effectivity of food supplements. Pharmaceutisch Weekblad (Netherlands) 06 AUG 1999, 134/31 (1034-1039).

260. Allan C.B., et al. Responsiveness of selenoproteins to dietary selenium. Annual Review of Nutrition (United States) 1999, 19/- (1-16).

261. Pfeiffer J.M., et al. Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training Wilderness and Environmental Medicine (United States) 1999, 10/2 (66-74).

262. Perrone L, et al. Long-term zinc and iron supplementation in children of short stature: Effect of growth and on trace element content in tissues Journal of Trace Elements in Medicine and Biology (Germany) 1999, 13/1-2 (51-56).

263. Horvathova M, et al. Effect of selenium supplementation in asthmatic subjects on the expression of endothelial cell adhesion molecules in culture. Biological Trace Element Research 1999, 69/1 (15-26).

264. Meletis C.D., et al. Natural medicine approaches for the treatment of degenerative arthritis. Alternative and Complementary Therapies 1999, 5/3 (136-139).

265. Young K.J., et al. Intervention studies on cancer. European Journal of Cancer Prevention 1999, 8/2 (91-103).

266. Nelson M.A., et al. Selenium and prostate cancer prevention Seminars in Urologic Oncology 1999, 17/2 (91-96).

267. Hermus R.J., et al. Clinical importance of extra vitamins from supplements and enriched foodstuffs. Nederlands Tijdschrift voor Geneeskunde 24 APR 1999, 143/17 (889-893).

268. Girodon F., et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: A randomized controlled trial. Archives of Internal Medicine 12APR 1999, 159/7 (748-754).

269. Jochum F, et al. Is there any health risk of low dietary selenium supply in PKU-children. Nutrition Research 1999, 19/3 (349-360).

270. Verdoy J, et al. Selenium and infant nutrition: A review. Acta Pediatrica Espanola 1999, 57/1 (3-11).